申请人:Vernalis Research Limited
公开号:US06433175B1
公开(公告)日:2002-08-13
A chemical compound of formula (I), wherein n is 1, 2 or 3; R1 and R2 are independently selected from hydrogen and alkyl; R3 is alkyl; R4 to R7 are independently selected from hydrogen, halogen, hydroxy, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, alkylsulfoxyl, alkylsulfonyl, arylsulfoxyl, arylsulfonyl, amino, monoalkylamino, dialkylamino, nitro, cyano, carboxaldehyde, alkylcarbonyl, arylcarbonyl, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonylamino, aminocarbonyloxy, monoalkylaminocarbonyloxy, dialkylaminocarbonyloxy, monoalkylaminocarbonylamino and dialkylaminocarbonylamino, or R5 and R6 together form a carbocyclic or heterocyclic ring, and pharmaceutically acceptable salts and prodrugs thereof, and the use thereof in therapy, particularly for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders, diabetes insipidus, and sleep apnea, and particularly for the treatment of obesity
化学式(I)的化合物,其中n为1、2或3;R1和R2独立选择自氢和烷基;R3为烷基;R4至R7独立选择自氢、卤素、羟基、烷基、芳基、烷氧基、芳氧基、烷基硫基、芳基硫基、烷基亚氧基、烷基磺醚基、芳基亚氧基、芳基磺醚基、氨基、单烷基氨基、双烷基氨基、硝基、氰基、羰基、烷基羰基、芳基羰基、氨基羰基、单烷基氨基羰基、双烷基氨基羰基、烷氧羰基氨基、氨基羰氧基、单烷基氨基羰氧基、双烷基氨基羰氧基、单烷基氨基羰基氨基和双烷基氨基羰基氨基,或R5和R6一起形成碳环或杂环,以及其药学上可接受的盐和前药,以及其在治疗中的使用,特别是用于治疗中枢神经系统紊乱;中枢神经系统损伤;心血管疾病;胃肠道疾病、尿崩症和睡眠呼吸暂停症,特别是用于肥胖症的治疗。